Patent applications and USPTO patent grants for CureTech Ltd..The latest application filed is for "monoclonal antibodies for tumor treatment".
Patent | Date |
---|---|
Pidilizumab monoclonal antibody therapy following stem cell transplantation Grant 9,580,504 - Rotem-Yehudar , et al. February 28, 2 | 2017-02-28 |
Variants of humanized immunomodulatory monoclonal antibodies Grant 9,416,175 - Rotem-Yehudar , et al. August 16, 2 | 2016-08-16 |
Monoclonal antibodies for tumor treatment Grant 9,309,308 - Rotem-Yehudar , et al. April 12, 2 | 2016-04-12 |
Monoclonal Antibodies For Tumor Treatment App 20140302032 - ROTEM-YEHUDAR; Rinat ;   et al. | 2014-10-09 |
Variants Of Humanized Immunomodulatory Monoclonal Antibodies App 20140220010 - ROTEM-YEHUDAR; Rinat ;   et al. | 2014-08-07 |
Monoclonal antibodies for tumor treatment Grant 8,747,847 - Rotem-Yehudar , et al. June 10, 2 | 2014-06-10 |
Variants of humanized immunomodulatory monoclonal antibodies Grant 8,686,119 - Rotem-Yehudar , et al. April 1, 2 | 2014-04-01 |
Variants Of Humanized Immunomodulatory Monoclonal Antibodies App 20130022595 - Rotem-Yehudar; Rinat ;   et al. | 2013-01-24 |
Humanized immunomodulatory monoclonal antibodies for the treatment of immunodeficiency Grant 7,981,416 - Hardy , et al. July 19, 2 | 2011-07-19 |
Peptide useful in immunomodulation Grant 7,745,397 - Hardy , et al. June 29, 2 | 2010-06-29 |
Human immunomodulatory monoclonal antibodies for the treatment of cancer Grant 7,524,498 - Hardy , et al. April 28, 2 | 2009-04-28 |
Peptide Useful In Immunomodulation App 20080175855 - Hardy; Britta ;   et al. | 2008-07-24 |
Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency Grant 7,332,582 - Hardy , et al. February 19, 2 | 2008-02-19 |
Peptide useful in immunomodulation Grant 7,329,639 - Hardy , et al. February 12, 2 | 2008-02-12 |
Humanized Immunomodulatory Monoclonal Antibodies For The Treatment Of Neoplastic Disease Or Immunodeficiency App 20080025980 - Hardy; Britta ;   et al. | 2008-01-31 |
Peptide useful in immunomodulation Grant 7,122,372 - Hardy , et al. October 17, 2 | 2006-10-17 |
Peptide useful in immunomodulation App 20060210573 - Hardy; Britta ;   et al. | 2006-09-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.